Ricin B Chain Enhances Immunotoxin Efficacy
Author Information
Author(s): J. Timar, D.P. McIntosh, R. Henry, A.J. Cumber, G.D. Parnell, A.J.S. Davies
Primary Institution: Institute of Pathology and Experimental Cancer Research, Semmelweis Medical University
Hypothesis
Does the presence of ricin B chain enhance the efficacy of the immunotoxin Fib75-SS-ricin A in targeting human bladder carcinoma cells?
Conclusion
The study found that ricin B chain significantly increases the toxicity of the immunotoxin Fib75-SS-ricin A and enhances the rate of protein synthesis inhibition in target cells.
Supporting Evidence
- Ricin B chain treatment increased the toxicity of the immunotoxin by two orders of magnitude.
- Cells treated with the immunotoxin and ricin B chain showed a significant increase in protein synthesis inhibition.
- Immunoelectron microscopy revealed differences in the internalization pathways of the immunotoxin with and without ricin B chain.
Takeaway
This study shows that adding ricin B chain to a cancer-targeting toxin makes it much better at killing cancer cells.
Methodology
The study used tissue culture and cytotoxicity assays on the EJ human bladder carcinoma cell line to assess the effects of ricin B chain on the immunotoxin.
Participant Demographics
Human bladder carcinoma cell line (EJ cells)
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website